FDAsafety guidance72% confidence
Positive Pressure Breathing Device Correction: Baxter Issues Correction for Volera Positive Pressure Breathing Devices
Source: FDA
Why This Matters
Why this matters: illustrates how regulators handled a comparable safety guidance decision relevant to Baxter.
Regulatory Analysis
Volara system patient circuits may leak air and medication from the nebulizer cup during therapy, leading to reduced oxygenation and ineffective nebulization.
Supporting Context
- Therapeutic area
- Medical Devices · IV Administration
- Sub-indication
- General
Related signal: Baxter Faces Early Alert Over Intravascular Administration Set Air Bubble Issue